Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation ...

A new Yale study has found a promising target for treating the brain fog that can follow COVID-19 and offers new insight into ...

The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest with recent years witnessing several important controversies.

Nanoparticles (NPs) are materials whose dimensions range from 1 to 1,000 nanometers (nm). Due to their nano-scale dimensions and tunable material properties, NPs have gained interest in the global ...

In the new study, Arutyunyan and colleagues probed the amyloid beta transition by exploring how changing the genetics of the peptide affects its aggregation rate.

One such study, published in 2019, suggested that one of the most definitive leads yet for a bacterial culprit behind Alzheimer's comes from a somewhat unexpected area: gum disease.

Cerebral amyloid angiopathy (CAA) is driven by vascular Aβ (amyloid‐beta) deposition, which can be detected as reduced Aβ species in cerebrospinal fluid (CSF). We sought to identify relationships ...

That influence seemed apparent in the years that followed a famous 2006 experiment in Nature that tied cognitive decline to a specific protein dubbed amyloid-beta*56.

Study suggests stalled amyloid protein production drives Alzheimer’s disease A study of rare familial genetic mutations linked to early-onset dementia supports the idea that stalled protein ...